Stockreport

ResMed cut at Oppenheimer after Eli Lilly's tirzepatide sleep apnea data [Seeking Alpha]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF the wake of encouraging data for Eli Lilly's ( NYSE: LLY ) weight loss therapy tirzepatide in obstructive sleep apnea (OSA). The Recommended For You More Trending [Read more]